Bayer | BAYN - Current Assets


Bayer reported EUR35.3B in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Air Liquide EUR 9.96B 33.3M Jun/2026
Akzo Nobel EUR 8.12B 594M Jun/2026
Alcon AG USD 6.62B 171M Mar/2026
Amarin USD 602.76M 23.26M Jun/2026
Arkema EUR 4.8B 37.7M Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
BASF EUR 38.79B 1.18B Jun/2026
Bayer EUR 35.3B 2.39B Mar/2026
Beiersdorf EUR 6.66B 8M Dec/2025
Corteva USD 16.36B 1.03B Jun/2026
Covestro EUR 5.91B 259M Dec/2025
Essilor EUR 11.24B 770M Jun/2026
Fresenius EUR 11.03B 1.03B Dec/2025
Fresenius Medical Care EUR 8.11B 209.55M Mar/2026
Genmab DKK 2.88B 1.59B Dec/2025
Givaudan CHF 4.07B 258M Dec/2025
GlaxoSmithKline GBP 17.56B 202M Jun/2026
GRIFOLS EUR 5.31B 51M Jun/2026
Henkel EUR 10.07B 268M Dec/2025
Hikma Pharmaceutical USD 2.64B 86M Dec/2025
Johnson Matthey GBP 3.94B 105M Jun/2026
Linde USD 12.75B 574M Mar/2026
Lonza CHF 8B 3.41B Dec/2025
Merck EUR 14.16B 932M Mar/2026
Novartis USD 27.35B 744M Jun/2026
Nutrien USD 16.48B 1.73B Mar/2026
Philips EUR 9.33B 454M Jun/2026
PPG Industries USD 8.26B 291M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 31.52B 1.36B Jun/2026
SAP EUR 22.65B 394M Jun/2026
Solvay EUR 2.05B 143M Jun/2026
UCB EUR 6.05B 733M Dec/2025
Umicore EUR 6.36B 621M Jun/2026
Vinci EUR 48.49B 1.07B Jun/2026